[Federal Register Volume 65, Number 22 (Wednesday, February 2, 2000)]
[Notices]
[Pages 4986-4987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-2313]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Care Financing Administration

[HCFA-3031-N]


Medicare Program; Meeting of the Executive Committee of the 
Medicare Coverage Advisory Committee--March 1, 2000

AGENCY:  Health Care Financing Administration (HCFA), HHS.

ACTION:  Notice of meeting.

-----------------------------------------------------------------------

SUMMARY:  This notice announces a public meeting of the Executive 
Committee of the Medicare Coverage Advisory Committee (MCAC). The 
Committee provides advice and recommendations to us about clinical 
coverage issues. The Committee will hear reports from its subcommittee, 
and will discuss and consider the levels of evidence (including the 
types and presentation format of information) that it believes should 
be considered by the medical specialty panels of the MCAC at future 
public meetings. Notice of this meeting is given under the Federal 
Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)).

DATES:  The Meeting: March 1, 2000, from 8 a.m. until 4 p.m., E.D.T.
    Deadline for Presentation Submissions: February 10, 2000.
    Special Accommodations: Persons attending the meeting who are 
hearing or visually impaired and have special requirements, or a 
condition that requires special assistance or accommodations, must 
notify the Executive Secretary by February 15, 2000.

ADDRESSES:  The Meeting: The meeting will be held at the Health Care 
Financing Administration, 7500 Security Boulevard, Baltimore, MD 21244.
    Presentations and Comments: Submit formal presentations and written 
comments to Sharon Lappalainen, Executive Secretary; Office of Clinical 
Standards and Quality; Health Care Financing Administration; 7500 
Security Boulevard; Mail Stop S3-02-01; Baltimore, MD 21244.
    Website: You may access up-to-date information on this meeting at 
www.hcfa.gov/quality/8b.htm.

FOR FURTHER INFORMATION CONTACT:  Sharon Lappalainen, Executive 
Secretary, (410) 786-9262.

SUPPLEMENTARY INFORMATION:  On August 13, 1999, we published a notice 
(64 FR 44231) describing the Medicare Coverage Advisory Committee 
(MCAC), which provides advice and recommendations to us about clinical 
coverage issues. This notice announces the following public meeting of 
the MCAC:

Current Members of the Panel

    Harold C. Sox, MD (Chairperson); Thomas V. Holohan, MD (FACP); 
Leslie P. Francis, JD, PhD; John H. Ferguson, MD; Robert L. Murray, 
PhD; Alan M. Garber, MD, PhD; Michael D. Maves, MD, MBA; David M. Eddy, 
MD, PhD; Frank J. Papatheofanis, MD, PhD; Ronald M. Davis, MD; Daisy 
Alford-Smith, PhD; Joe W. Johnson, DC; Robert H. Brook, MD, ScD; Linda 
A. Bergthold, PhD; Randel E. Richner, MPH.

Topic of the Meeting

    The Committee will hear reports from its subcommittee, and will 
discuss and consider the levels of evidence (including the types and 
presentation

[[Page 4987]]

format of information) that it believes should be considered by the 
medical specialty panels of the MCAC at future public meetings.

Procedure and Agenda

    This meeting is open to the public. The Committee will hear oral 
presentations from the public for approximately one hour. The Committee 
may limit the number and duration of oral presentations to the time 
available. If you wish to make a formal presentation, you must notify 
the For Further Information Contact, and submit the following by the 
Deadline for Presentations and Comments date listed in the DATES 
section of this notice: a brief statement of the general nature of the 
evidence or arguments you wish to present, the names and addresses of 
proposed participants, and an estimate of the time required to make the 
presentation. We will request that you declare at the meeting whether 
or not you have any financial involvement with manufacturers of any 
items or services being discussed (or with their competitors).
    After the public presentation, we will make a presentation to the 
Committee. After our presentation, the Committee will deliberate openly 
on the topic. Interested persons may observe the deliberations, but the 
Committee will not hear further comments during this time except at the 
request of the chairperson. At the end of the Committee deliberations, 
the Committee will allow a 30-minute open public session for any 
attendee to address issues specific to the topic. After which, the 
members will vote and the Committee will make its recommendation.

    Authority:  5 U.S.C. App. 2, section 10(a)(1) and (a)(2).

(Catalog of Federal Domestic Assistance Program No. 93.774, 
Medicare-Supplementary Medical Insurance Program)

    Dated: January 18, 2000.
Jeffrey L. Kang,
Director, Office of Clinical Standards and Quality, Health Care 
Financing Administration.
[FR Doc. 00-2313 Filed 2-1-00; 8:45 am]
BILLING CODE 4120-01-P